These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11231971)

  • 21. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast-cancer risk: higher with estrogen-progestin than estrogen alone.
    Miller JL
    Am J Health Syst Pharm; 2000 Apr; 57(7):635-6. PubMed ID: 10768814
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
    von Schoultz B; Bergkvist L; Magnusson C; von Schoultz E
    Lakartidningen; 2000 May; 97(18):2225-6. PubMed ID: 10850053
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 25. Progesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapies.
    Schairer C
    Breast Cancer Res; 2002; 4(6):244-8. PubMed ID: 12473171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement. HRT forum: progestins.
    Harv Womens Health Watch; 2000 Sep; 8(1):3-5. PubMed ID: 10966600
    [No Abstract]   [Full Text] [Related]  

  • 28. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous combined hormone replacement therapy and risk of endometrial cancer.
    Hill DA; Weiss NS; Beresford SA; Voigt LF; Daling JR; Stanford JL; Self S
    Am J Obstet Gynecol; 2000 Dec; 183(6):1456-61. PubMed ID: 11120510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 31. Study outlines further risks associated with hormone replacement therapy.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):1-2, 5. PubMed ID: 13677336
    [No Abstract]   [Full Text] [Related]  

  • 32. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 33. The risk of breast cancer linked to menopausal hormone therapy.
    Sæther S; Bakken K; Lund E
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1330-4. PubMed ID: 22717857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 36. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
    Zbuk K; Anand SS
    J Epidemiol Community Health; 2012 Jan; 66(1):1-7. PubMed ID: 21875869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy and breast cancer.
    Stanford JL; Weiss NS
    Arch Fam Med; 1996 Jun; 5(6):349-50. PubMed ID: 8640325
    [No Abstract]   [Full Text] [Related]  

  • 38. Women's health. U.K. hormone trial to pause for review.
    Enserink M
    Science; 2002 Aug; 297(5582):755-7. PubMed ID: 12161626
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormone replacement therapy and risk of breast cancer: the role of progestins.
    Stahlberg C; Pedersen AT; Lynge E; Ottesen B
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.